跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
triazine derivatives
首页
药物
triazine derivatives
triazine derivatives
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
TRIAZINE DERIVATIVES FOR TREATING DISEASES RELATING TO NEUROTROPHINS
EP 3759088 B1
申请人: ALZECURE PHARMA AB
优先权: 2018
EP
US
WO
7 件公开
US 2022324819 A1
申请人: ALZECURE PHARMA AB
优先权: 2019
CN
EP
US
WO
4 件公开
Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses
US 7034021 B2
申请人: LIPHA
优先权: 2000
US
7 件公开
Substituted diamino-1,3,5-triazine derivatives
US 6962916 B2
申请人: JANSSEN PHARMACEUTICA NV
优先权: 2001
US
6 件公开
PHARMACEUTICALLY ACTIVE PYRAZOLO-TRIAZINE AND/OR PYRAZOLO-PYRIMIDINE DERIVATIVES
EP 3774809 A1
申请人: QURIENT CO LTD
优先权: 2018
CN
EP
US
WO
5 件公开
US 2022098208 A1
申请人: QURIENT CO LTD
优先权: 2021
US
2 件公开
Medical use of triazine derivatives
US 8268823 B2
申请人: LEACH MICHAEL
优先权: 2006
CN
US
5 件公开
Triazine derivatives and their therapeutical applications
US 7858782 B2
申请人: ABRAXIS BIOSCIENCE LLC
优先权: 2007
CN
US
5 件公开
US 2012172361 A1
申请人: TAO CHUNLIN
优先权: 2010
CN
US
2 件公开
US 2013023497 A1
申请人: TAO CHUNLIN
优先权: 2010
CN
US
2 件公开
CN 105175409 A
申请人: CALIFORNIA CAPITAL EQUITY LLC
优先权: 2010
CN
US
2 件公开
US 9078902 B2
申请人: TAO CHUNLIN
优先权: 2010
US
2 件公开
Combination of insulin with triazine derivatives
US 8592370 B2
申请人: MESANGEAU DIDIER
优先权: 2008
CN
US
5 件公开
1,2,4-triazine-4-amine derivatives
US 8809525 B2
申请人: CONGREVE MILES STUART
优先权: 2011
US
5 件公开
Triazine derivatives
US 8933224 B2
申请人: PFIZER
优先权: 2014
US
5 件公开
US 8444879 B2
申请人: EHLIS THOMAS
优先权: 2006
US
2 件公开
US 8895731 B2
申请人: MAESTRI FRANCESCO
优先权: 2012
US
2 件公开
US 6193960 B1
申请人: CIBA SC HOLDING AG
优先权: 2000
US
CN 116496266 A
申请人: ASCLETIS BIOTECHNOLOGY HANGZHOU CO LTD
优先权: 2022
CN
WO 2025252772 A1
申请人: HOFFMANN LA ROCHE
优先权: 2024
WO
COMBINATION OF TRIAZINE DERIVATIVES AND PPARalpha AGONISTS
US 2010159005 A1
申请人: MOINET GERARD
优先权: 2006
CN
EP
US
WO
4 件公开
第 1 / 9 页
上一页
下一页
药物
反馈